Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together
Biotech

BMS inks $15B deal to bag Hengrui assets, tap China’s R&D speed

BMS formed a broad partnership with Hengrui, paying $600 million upfront to advance 13 early-stage programs from across the two companies’ pipelines.
Nick Paul Taylor May 12, 2026 1:56am
Sketch of lungs

Enterprise posts CF win, succeeding where Big Pharma stumbled

May 12, 2026 4:00am
syneos-herov2-04302026png

MRD as a Decision Engine: Rethinking Oncology Trial Design

Brought to you by Syneos Health
sale sold deal

Novo salvages happy ending for scrapped Parkinson’s therapy

May 11, 2026 8:30am
Collage poster study of businessmen picture chart arrow goes up
Favicon Fierce Pharma

Daiichi Sankyo targets global top 5 oncology rank by 2035

May 11, 2026 10:22am
green light go go ahead advance yes streetlight

Inhibrx’s OX40-Keytruda combo shows promise in early ph. 2 data

May 11, 2026 10:06am
More News

Amgen-backed quantum computing firm plans IPO

May 10, 2026 8:25am
Fierce Pharma

Trump plans to end stormy 14-month tenure of FDA chief Makary

May 8, 2026 3:38pm

Protective gene sent to the liver cleared brain amyloid in mice

May 8, 2026 1:15pm

EnGene cancer sales forecast cut after new data widen gap to J&J

May 8, 2026 9:08am